ISG20 Antikörper (Middle Region)
Kurzübersicht für ISG20 Antikörper (Middle Region) (ABIN952958)
Target
Alle ISG20 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 28-58, Middle Region
-
Spezifität
- This antibody recognizes Human ISG20 / HEM45 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 28-58 amino acids from the Central region of Human ISG20 / HEM45
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ISG20 (Interferon Stimulated Exonuclease Gene 20kDa (ISG20))
-
Andere Bezeichnung
- ISG20 / HEM45
-
Hintergrund
- Exonuclease with specificity for single-stranded RNA and, to a lesser extent for DNA. Degrades RNA at a rate that is approximately 35-fold higher than its rate for single-stranded DNA. Involved in the antiviral function of IFN against RNA viruses.Synonyms: Estrogen-regulated transcript 45 protein, Interferon-stimulated gene 20 kDa protein, Promyelocytic leukemia nuclear body-associated protein ISG20
-
Molekulargewicht
- 20363 Da
-
Gen-ID
- 3669
-
NCBI Accession
- NP_002192
Target
-